60-Second ROI Simulator
Three questions. One honest projection.
Built for MDs and Clinical Chiefs. No form-wall, no lead-capture pop-ups. Answer three questions and see whether we're the right growth partner for your next 12 months — before you spend a minute on a call.
FOUNDER'S READ
This is a strong fit for a founder-led engagement.
Payback in 0.6 months on an indicative ₹36.0 L Blueprint. We would take this call.
INCREMENTAL EBITDA / YR
₹7.11 Cr
+55 admissions/mo × 28%
BLENDED ROAS
19.3×
on ₹18.0 L spend
ENGAGEMENT PAYBACK
0.6 mo
₹36.0 L Blueprint bundle
HOW WE GOT THERE
- Post-Protocol conversion(from 22% today)
- 36%
- Qualified enquiries / mo
- 250
- Projected CAC / admission(bench ₹22,000)
- ₹20,000
- OT sessions consumed
- 56 / 140
- Ramp to steady state
- 10 weeks
DIAGNOSTICS
What we'd flag on a founder-led call
- CAC is healthy for Cardiac Sciences in a Metro catchment.
- OT capacity absorbs the target (40% utilisation).
- ROAS 19.3× sits in the top quartile.
NEXT STEP · 48-HOUR TURNAROUND
Request your Surgical Pipeline Blueprint.
A founding partner reviews these inputs against your catchment and HIS attribution, and returns a fixed-scope blueprint in 48 hours. Max 3 engagements per quarter — currently 2 open for FY26 Q2.
No sales calls. No email drips. If we're not a fit, we'll say so on the first call.
METHODOLOGY
Benchmarks from 47 super-specialty programs (India & GCC, FY23–FY26), normalised to HIS-verified admission source and procedure code. No self-reported metrics.
GOVERNANCE
Communications governed by NMC advertising code. No patient PII processed by this tool. See our clinical governance posture.
HONEST BROKER
If your payback runs beyond 6 months, we'll tell you — and decline the engagement. Founder-led practice, no annual retainers.